XML 35 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (DEFICIT) (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Equity [Abstract]    
Fair Value, by Balance Sheet Grouping [Table Text Block]  
In estimating the warrants' fair value, the Company used the following assumptions:
 
Investors warrants:
 
 
 
Issuance
date
 
 
December 31,
2012
 
 
December 31,
2011
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
1.2
%
 
 
0.51
%
 
 
0.78
%
Expected volatility (2)
 
 
80
%
 
 
70
%
 
 
80
%
Expected life (in years) (3)
 
 
5
 
 
 
3.82
 
 
 
4.79
 
Expected dividend yield (4)
 
 
0
 
 
 
0
 
 
 
0
 
Fair value:
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
0.39
 
 
$
0.81
 
 
$
0.38
 
 
Placement agent warrants:
 
 
 
Issuance
date
 
 
December 31,
2012
 
 
December 31,
2011
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
0.86
%
 
 
0.41
%
 
 
0.53
%
Expected volatility (2)
 
 
75
%
 
 
59
%
 
 
75
%
Expected life (in years) (3)
 
 
3.93
 
 
 
3.25
 
 
 
3.71
 
Expected dividend yield (4)
 
 
0
 
 
 
0
 
 
 
0
 
Fair value:
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
$
0.31-0.32
 
 
$
0.65-0.79
 
 
$
0.29-0.32
 
 
(1)
Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.
 
(2)
Expected volatility - was calculated based on actual historical stock price movements of companies in the same industry over aterm that is equivalent to the expected term of the option.
 
(3)
Expected life - the expected life was based on the maturity date of the warrants.
  
(4)
Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future.
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]  
Transactions related to the grant of options to employees, directors and non employees under the above plans during the year ended December 31, 2012, were as follows:
 
 
 
Number of
options
 
Weighted
average
exercise
price
 
Weighted
average
remaining
contractual
life
 
Intrinsic
value
 
 
 
 
 
 
$
 
Years
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at beginning of year
 
 
-
 
 
-
 
 
-
 
 
-
 
Options granted (*)
 
 
2,100,000
 
 
0.32
 
 
 
 
 
 
 
Options exercised
 
 
-
 
 
-
 
 
 
 
 
 
 
Options expired
 
 
-
 
 
-
 
 
 
 
 
 
 
Options forfeited
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at end of year
 
 
2,100,000
 
 
0.32
 
 
7.69
 
 
1.18
 
 
 
Options vested and expected to vest at end of
    year
 
2,086,750
 
0.24
 
7.17
 
1.17
 
 
 
 
 
 
 
 
 
 
 
Exercisable at end of year
 
1,045,000
 
0.16
 
6.88
 
1.18
 
 
(*) Excluding 500,000 restricted shares granted (see also Note 8h).
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]  
The following table presents the weighted-average assumptions used to estimate the fair values of the options granted in the period presented:
 
 
 
Year ended
December 31,
2012
 
 
 
 
 
 
Volatility
 
 
49.9%-75.1
%
Risk-free interest rate
 
 
0.37%-0.96
%
Dividend yield
 
 
0
%
Expected life (years)
 
 
2.5-5
 
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The total compensation cost related to all of the Company's equity-based awards, recognized during the period of six and three months ended June 30, 2013 was comprised as follows:
 
 
 
Three
months
ended
June 30,
2013
 
Six months
ended
June 30,
2013
 
Research and development
 
$
171,679
 
$
380,490
 
Marketing and pre-production costs
 
 
80,186
 
 
111,840
 
General and administrative
 
 
279,607
 
 
1,358,540
 
 
 
 
 
 
 
 
 
Total stock-based compensation expenses
 
$
531,472
 
$
1,850,870
 
The total compensation cost related to all of the Company's equity-based awards, recognized during year ended December 31, 2012 was comprised as follows:
 
 
 
Year ended
December 31,
2012
 
 
 
 
 
 
Research and development
 
$
173,740
 
General and administrative
 
 
390,403
 
Total stock-based compensation expenses
 
$
564,143